<DOC>
	<DOC>NCT01755650</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and potential effectiveness of the imaging compound 18F FPM for finding sites of malignancies.</brief_summary>
	<brief_title>Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<criteria>Written informed consent obtained prior to any protocolspecific procedures Male and female patients with histologically confirmed squamous cell carcinoma At least one site of active malignancy, as demonstrated on the prestudy 18F FDG PET/CT scan performed as part of routine clinical care Age &gt;/= 18 years Life expectancy &gt;/= 3 months ECOG Performance score of 02 Pregnant or breastfeeding females Systemic antineoplastic therapy within the 2 weeks prior to the prestudy 18F FDG PET/CT scan until after the 18F FPM PET/CT scan Any serious medical condition which the investigator feels may interfere with the procedures or evaluations of the study Patients unwilling or unable to comply with protocol or with a history of noncompliance or inability to grant informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>18F FPM</keyword>
	<keyword>PET/CT</keyword>
	<keyword>microdosing</keyword>
</DOC>